Treatment Adherence in Patients with Headache: a Systematic Review

Overview

Journal Headache

Publisher Wiley

Specialties Neurology
Psychiatry

Date 2014 Apr 23

PMID 24750017

Citations 35

Authors

Rachelle R Ramsey

Jamie L Ryan

Andrew D Hershey

Scott W Powers

Brandon S Aylward

Kevin A Hommel

Affiliations

Soon will be listed here.

Abstract

Objective: To review and critically evaluate the extant research literature pertaining to adherence in youth and adults with headache and to provide recommendations for future research.

Background: This article provides the first systematic review of pediatric headache adherence and updates a previous review of treatment adherence in adults with headache.

Design: Systematic review of empirical literature.

Methods: A literature search with no date restriction was conducted using PubMed and PsycINFO electronic databases and bibliographies of relevant articles.

Results: Adherence rates in adults with headache range considerably from 25% to 94% across treatment, assessment method, and definition of adherence utilized. Methods to assess adherence included retrospective prescription claims data, paper or electronic diaries, follow-up appointment attendance, written and verbal self-report of general adherence, verbal self-report of adherence over a specific amount of time via in person interview or telephone, validated adherence measures, adherence questionnaires without validation, and counselor ratings of homework. Each methodology and assessment tool demonstrated strengths and weaknesses. No studies have systematically examined medication adherence in children with headache, and the few available studies examining adherence to behavioral treatment have documented adherence rates ranging from 52% to 86%.

Conclusions: Adherence research in adults with headache is growing, but studies demonstrate a number of methodological shortcomings. Adherence research in children with headache, and adherence intervention research in both adults and children, is scant. Future research should use objective measures of adherence, consider over-the-counter medications and medication overuse, examine demographic, psychological, and behavioral correlates of adherence, assess adherence to botulinum toxin type A, and examine the efficacy of adherence interventions in individuals with headache.

Citing Articles

Effects of neck-exercise and health promotion on headache outcomes in office workers: secondary analysis of the NEXpro stepped wedge cluster randomised controlled trial.

Ernst M, Meichtry A, Luedtke K, Falla D J Headache Pain. 2025; 26(1):30.

PMID: 39939850 PMC: 11817237. DOI: 10.1186/s10194-025-01963-y.

Treatment adherence: A Concept Analysis Using the Walker & Avant Method.

Tang J, Klunklin P, Lirtmunlikaporn S, Wang Y Patient Prefer Adherence. 2024; 18:2067-2075.

PMID: 39371196 PMC: 11453142. DOI: 10.2147/PPA.S477615.

Implementing a digital solution for patients with migraine-Developing a methodology for comparing digitally delivered treatment with conventional treatment: A study protocol.

Niiberg-Pikksoot T, Laas K, Aluoja A, Braschinsky M PLOS Digit Health. 2024; 3(2):e0000295.

PMID: 38421955 PMC: 10903846. DOI: 10.1371/journal.pdig.0000295.

Neuromodulation for the Sphenopalatine Ganglion-a Narrative Review.

Lim T, Anderson S, Stocum R, Ren K, Singleton W, Vallabh J Curr Pain Headache Rep. 2023; 27(11):645-651.

PMID: 37610504 DOI: 10.1007/s11916-023-01132-3.

Medication adherence in patients with cluster headache and migraine: an online survey.

Rimmele F, Muller B, Becker-Hingst N, Wegener S, Rimmele S, Kropp P Sci Rep. 2023; 13(1):4546.

PMID: 36941306 PMC: 10027659. DOI: 10.1038/s41598-023-30854-y.

References

Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G . Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006; 26(9):1097-105. DOI: 10.1111/j.1468-2982.2006.01175.x. View

Foley K, Cady R, Martin V, Adelman J, Diamond M, Bell C . Treating early versus treating mild: timing of migraine prescription medications among patients with diagnosed migraine. Headache. 2005; 45(5):538-45. DOI: 10.1111/j.1526-4610.2005.05107.x. View

Cady R, Maizels M, Reeves D, Levinson D, Evans J . Predictors of adherence to triptans: factors of sustained vs lapsed users. Headache. 2009; 49(3):386-94. DOI: 10.1111/j.1526-4610.2009.01343.x. View

Allen K, McKeen L . Home-based multicomponent treatment of pediatric migraine. Headache. 1991; 31(7):467-72. DOI: 10.1111/j.1526-4610.1991.hed3107467.x. View

Heckman B, Ellis G . Preventive medication adherence in African American and Caucasian headache patients. Headache. 2011; 51(4):520-32. DOI: 10.1111/j.1526-4610.2011.01866.x. View

Hommel K, Davis C, Baldassano R . Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2008; 15(4):589-93. PMC: 2663377. DOI: 10.1002/ibd.20798. View

Ferrari A, Stefani M, Sternieri S, Bertolotti M, Sternieri E . Analgesic drug taking: beliefs and behavior among headache patients. Headache. 1997; 37(2):88-94. DOI: 10.1046/j.1526-4610.1997.3702088.x. View

Attar H, Chandramani S . Impact of physician empathy on migraine disability and migraineur compliance. Ann Indian Acad Neurol. 2012; 15(Suppl 1):S89-94. PMC: 3444220. DOI: 10.4103/0972-2327.100025. View

Rains J, Lipchik G, Penzien D . Behavioral facilitation of medical treatment for headache--part I: Review of headache treatment compliance. Headache. 2006; 46(9):1387-94. DOI: 10.1111/j.1526-4610.2006.00581.x. View

10.

Hedenrud T, Jonsson P, Linde M . Beliefs about medicines and adherence among Swedish migraineurs. Ann Pharmacother. 2007; 42(1):39-45. DOI: 10.1345/aph.1K354. View

11.

Etemad L, Yang W, Globe D, Barlev A, Johnson K . Costs and utilization of triptan users who receive drug prophylaxis for migraine versus triptan users who do not receive drug prophylaxis. J Manag Care Pharm. 2005; 11(2):137-44. PMC: 10438223. DOI: 10.18553/jmcp.2005.11.2.137. View

12.

Spierings E, Miree L . Non-compliance with follow-up and improvement after treatment at a headache center. Headache. 1993; 33(4):205-9. DOI: 10.1111/j.1526-4610.1993.hed33040205.x. View

13.

Donnet A, Lanteri-Minet M, Aucoin F, Allaf B . Use and overuse of antimigraine drugs by pharmacy personnel in France: COTA survey. Headache. 2009; 49(7):1014-21. DOI: 10.1111/j.1526-4610.2009.01395.x. View

14.

Holroyd K, Powers S, Andrasik F . Methodological issues in clinical trials of drug and behavior therapies. Headache. 2005; 45(5):487-92. DOI: 10.1111/j.1526-4610.2005.05100.x. View

15.

Sorbi M, Mak S, Houtveen J, Kleiboer A, van Doornen L . Mobile Web-based monitoring and coaching: feasibility in chronic migraine. J Med Internet Res. 2008; 9(5):e38. PMC: 2270417. DOI: 10.2196/jmir.9.5.e38. View

16.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

17.

Golden W, Evans J, Hu H . Migraine strikes study: factors in patients' decision to treat early. J Headache Pain. 2009; 10(2):93-9. PMC: 3451646. DOI: 10.1007/s10194-008-0091-1. View

18.

Ifergane G, Wirguin I, Shvartzman P . Triptans--why once?. Headache. 2006; 46(8):1261-3. DOI: 10.1111/j.1526-4610.2006.00435.x. View

19.

Ezra Y, Gotkine M, Goldman S, Adahan H, Ben-Hur T . Hypnotic relaxation vs amitriptyline for tension-type headache: let the patient choose. Headache. 2011; 52(5):785-91. DOI: 10.1111/j.1526-4610.2011.02055.x. View

20.

Terwindt G, Ferrari M, Tijhuis M, Groenen S, Picavet H, Launer L . The impact of migraine on quality of life in the general population: the GEM study. Neurology. 2000; 55(5):624-9. DOI: 10.1212/wnl.55.5.624. View